Michael Scolaro

Michael Scolaro

Oct 18, 2017

Group 6 Copy 36
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Backer Badge Funded